Drug stock price sector rotation patterns suggest drug

Sector rotation patterns suggest drug stock price could benefit from volatility in tech. Merck & Co (MRK) edged up to $127.50, with oncology drug sales cited as key growth drivers in analyst updates. TrumpRx.gov aims to sell drugs directly to consumers, bypassing Pharmacy Benefit Managers. But some of the stocks have lagged the S&P 500 for years, and even decades. Seasonal trading patterns show drug stock price often climbs during FDA approval windows in late summer. This historically adds 4–6% to biotech indexes across August and September.